Literature DB >> 14651676

Use of health-related quality of life in prescribing research. Part 1: why evaluate health-related quality of life?

M J Calvert1, N Freemantle.   

Abstract

Clinicians, regulatory authorities, and pharmaceutical companies increasingly recognize the importance of assessing the patient's perspective on the impact of disease and its treatment on their health-related quality of life (HRQoL). This article describes the importance of assessing HRQoL, particularly in patients with chronic disease, provides examples of the different types of instrument available for measuring HRQoL and considers how such assessment can aid medical-decision making. In addition we consider the potential role of HRQoL assessment in routine clinical practice, and its use in licensing and health technology appraisal.

Entities:  

Mesh:

Year:  2003        PMID: 14651676     DOI: 10.1046/j.0269-4727.2003.00521.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  27 in total

1.  Validation of the EQ-5D quality of life instrument in patients after myocardial infarction.

Authors:  David Nowels; Joe McGloin; John M Westfall; Sherry Holcomb
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

2.  Putting patient-reported outcomes on the 'Big Data Road Map'.

Authors:  Melanie Calvert; Rob Thwaites; Derek Kyte; Nancy Devlin
Journal:  J R Soc Med       Date:  2015-03-31       Impact factor: 5.344

Review 3.  Measurement properties of rheumatoid arthritis-specific quality-of-life questionnaires: systematic review of the literature.

Authors:  Jiyeon Lee; Soo Hyun Kim; Seung Hei Moon; Eun-Hyun Lee
Journal:  Qual Life Res       Date:  2014-05-21       Impact factor: 4.147

Review 4.  Assessment of Quality of Life in Migraine.

Authors:  Özlem Taşkapilioğlu; Necdet Karli
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

5.  Experiences with the FACT-EGFRI-18 instrument in EGFRI-associated mucocutaneous adverse events.

Authors:  Christine B Boers-Doets; Hans Gelderblom; Mario E Lacouture; Joel B Epstein; Johan W R Nortier; Ad A Kaptein
Journal:  Support Care Cancer       Date:  2013-02-17       Impact factor: 3.603

6.  Quality of life assessment in migraine and relapsing remitting multiple sclerosis: self-perceived health is similar.

Authors:  Klaudia Duka Glavor; Marina Titlić; Gorka Vuletić; Anamarija Mrđen; Marina Maras Šimunić
Journal:  Neurol Sci       Date:  2019-07-17       Impact factor: 3.307

Review 7.  A systematic review of measurement properties of the instruments measuring health-related quality of life in patients with irritable bowel syndrome.

Authors:  Jiyeon Lee; Eun-Hyun Lee; Seung Hei Moon
Journal:  Qual Life Res       Date:  2016-09-29       Impact factor: 4.147

8.  COVID-NURSE: evaluation of a fundamental nursing care protocol compared with care as usual on experience of care for noninvasively ventilated patients in hospital with the SARS-CoV-2 virus-protocol for a cluster randomised controlled trial.

Authors:  David A Richards; Holly Vr Sugg; Emma Cockcroft; Joanne Cooper; Susanne Cruickshank; Faye Doris; Claire Hulme; Phillipa Logan; Heather Iles-Smith; G J Melendez-Torres; Anne Marie Rafferty; Nigel Reed; Anne-Marie Russell; Maggie Shepherd; Sally J Singh; Jo Thompson Coon; Susannah Tooze; Stephen Wootton; Rebecca Abbott; Alison Bethel; Siobhan Creanor; Lynne Quinn; Harry Tripp; Fiona C Warren; Rebecca Whear; Jessica Bollen; Harriet A Hunt; Merryn Kent; Leila Morgan; Naomi Morley; Lidia Romanczuk
Journal:  BMJ Open       Date:  2021-05-26       Impact factor: 2.692

9.  Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialists.

Authors:  Derek Kyte; Jonathan Ives; Heather Draper; Thomas Keeley; Melanie Calvert
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

Review 10.  Patient reported outcomes (PROs) in clinical trials: is 'in-trial' guidance lacking? a systematic review.

Authors:  Derek G Kyte; Heather Draper; Jonathan Ives; Clive Liles; Adrian Gheorghe; Melanie Calvert
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.